2018 Annual MeetingOctober 2, 2018

San Francisco, California

Elizabeth Dodds Ashley, PharmD, MHSSIDP President

Program Agenda12:00 - 12:30 pm President’s Welcome & Business Meeting

SIDP President

12:30 – 1:15 pm SIDP Strategic Planning Bylaw Member Voting

1:15 – 2:00 pm Dueling Recommendations: When to Use Dual Therapy Julie Ann Justo, PharmD, MS, BCPS-AQ ID

ACPE: 0221-9999-18-378-L01-P

2:00 – 2:45 pm Adult Vaccines in 2018: Where Do We Start? Jeff Goad, PharmD, MPH, FAPhA, FISTM, FCPhA, FCSHP

ACPE: 0221-9999-18-379-L01-P

2:45 – 3:15 pm Break With Research Award Posters

3:15 – 4:00 pm Strategies to Decrease Vancomycin-Associated Nephrotoxicity: What Is Their Worth?Kari Mergenhagen, PharmD, BCPS (AQ-ID) and Emi Minejima, PharmD

ACPE: 0221-9999-18-380-L01-P

4:00 – 4:30 pm Infectious Diseases Team Trivia Douglas Slain, PharmD, BCPS, FCCP, FASHP

ACPE: 0221-9999-18-381-L01-P

4:30 – 5:15 pm Keynote Lecture: Policy Advocacy for Your Community Kavita K. Trivedi, MD, Principal, Trivedi Consults, LLC andSanjay Ranchod, JD, Director and Counsel, Tesla

ACPE: 0221-9999-18-382-L03-P

5:15 – 6:00 pm Recognition and Fellow of SIDP Awards Installation of the Incoming Board Members

6:00 – 9:00 pm Reception

DEADLINE to submit – November 2, 2018

The CE sessions are partially supported by an educational grant from BioFire Diagnostics.

Annual Meeting San Francisco CA October 2, 2018

Team Trivia!teams compete for SIDP bragging rights and swagcategories: < 5 yrs and > 5 yrs in practice (s/p training)way to enter: submit an index card with your name to

volunteers at the registration table

Gold Sponsors

2018 Annual Meeting Sponsors

2018 Annual Meeting Sponsors

Silver Sponsors

2018 Annual Meeting Sponsors

Bronze Sponsor

Reception Sponsor

Annual Meeting San Francisco CA October 2, 2018

Business Report Elizabeth Dodds Ashley, PharmD, MHS

SIDP President

SIDP Board Members and Roles

Immediate Past President

Melinda Neuhauser, PharmD, MPHChicago, IL

Secretary/Treasurer

Emily L. Heil, PharmD, BCPS AQ-ID, AAHIVPUniversity of Maryland School of Pharmacy

President

Elizabeth Dodds Ashley PharmD, MHSDuke Antimicrobial Stewardship Outreach Network

President-Elect

Kerry LaPlante, PharmDThe University of Rhode Island

SIDP Board Members and RolesMember-at-Large

Amy Pakyz, PharmD, MSVirginia Commonwealth University

Member-at-Large

Susan Davis, PharmDWayne State University

Annual Meeting San Francisco CA October 2, 2018

Major Accomplishments2017 - 2018

Major AccomplishmentsNew management company!

SIDP Podcast!

BPS-approved BCID recertification provider!

Advocacy Opportunities

5,000 followers on Twitter!

Support for Global AMR Challenge

New Management

January 2, 2018

CEO | Elizabeth A. Schumacher, JD

Podcast Series

Panelists: Moderator:

Julie Ann Justo Bruce M. Jones Mari L. Staicu Jason M. Pogue

Available Now! www.sidp.org/podcasts

Scan QR code to access podcast

BPS-Approved Development Provider Status

BCIDPRecertification

Advocacy

Twitter: Over 5,000 Followers!

Scan QR code to follow us on Twitter

@SIDPharm

More details: https://www.cdc.gov/drugresistance/intl-activities/amr-challenge.html

Global AMR Challenge

Annual Meeting San Francisco CA October 2, 2018

Treasurer’s Report, 2017-18

Emily HeilSecretary/Treasurer

2017-2018 Income8%

5%

18%

51%

4%

5%

3%3% 3% Dues

UBS Interest and Dividends

Annual and Off-Cycle MeetingSponsorsAcute Care Stewardship Program

Long Term Care StewardshipProgramWebsite Sponsorship

Residency Award

Research Grants

Miscellaneous

2017-2018 Expenses

30%

18%11%

19%

13%

2% 4%

2%

1%

Stewardship ProgramsResearch GrantsResidency AwardSIDP Annual MeetingAffinity Management FeeEAMI Management FeeWebpage/CreativeInvestments and Banking FeesBoard Travel/Strategic Planning

Balance Comparison 2014 – 2018 (Updated 8/31/2018)

$0

$500,000

$1,000,000

$1,500,000

$2,000,000

$2,500,000

2014 2015 2016 2017 2018

Total AssetsLiabilitiesNet Worth

Financial Notes• Audit completed in 2017 for 2016 Uneventful; minor bookkeeping recommendations to be

completed with CPA Annual audit planned

• Investment manager evaluation and investment policy development

• Exploring quasi-endowment for sustainable research and grant funding

Annual Meeting San Francisco CA October 2, 2018

Residency Grants

SIDP/Allergan ID Pharmacotherapy Residency Grant, 2018-2019

Parkland Hospital, Dallas, Texas PGY2 Infectious Diseases Residency

Director: Jessica Ortwine, PharmDResident: Kevin Lin, PharmD

SIDP ID Pharmacotherapy Residency GrantSupported by: BioMerieux and Allergan, Inc

2019-2020

Denver Health Medical CenterPGY2 Infectious Diseases Residency

Director: Kati Shihadeh, PharmDResident: TBD

Annual Meeting San Francisco CA October 2, 2018

SIDP Annual Meeting 2018Committee Reports

Thank You!

Elections/Nominations

Fundraising

Internet/Social Media

Inter-Organizational Engagement

Membership

Political AdvocacyPrograms

Publications

Recognition

Research

SIDPEC

Stewardship

Annual Report

13 SIDP Committees 2018

Committee Structure

Annu

al R

epor

t • Earliest ever draft annual report!

• Working with Affinity Strategies to update to new graphics for 2018

Mem

bers

hip • Developed new

member toolkit• Reviewed and

approved 255 new members

• 28 active, 9 associate, 143 associate (stewardship), 75 trainee

• Transitioned review and approval for associate an trainee to Affinity Strategies

Elec

tions • Successful and

seamless special election

• Successful slate of election for new President-elect, Secretary/Treasurer and Board Member at Large

Election Results• Board Member at Large • Secretary/Treasurer

Douglas N. Fish, PharmD Emily L. Heil, PharmD

Election Results• President-elect

Jason Pogue, PharmD

SIDP

EC • Enduring material• 2017 Annual Meeting• ASHP symposium• Transplant series• Recording current

meeting• CLSI webinar• Grants submitted to

support AMR challenge• 10/18/18 Vancomycin

dosing webinar• Upcoming: ASHP, 3

dedicated webinars in 2019

Stew

ards

hip • Acute Care

• > 4000 participants enrolled

• Close to 400 new students enrolled

• 300 students completed in 2018 to date

• Long Term Care• 74 students enrolled

to date• 10 students

completed

Prog

ram

s

Polit

ical

Adv

ocac

y 1.Development of an infographic to provide a concise description of our organization to allow for further promotion of ID Pharmacy related advocacy

2.Involvement in the endorsement of key legislation throughout the year that promotes to integral role of the ID Pharmacist

Inte

r-or

gani

zatio

nal

Enga

gem

ent • Several co-sponsored

sessions for 2018 and 2019:• SHEA, ASWR, ASHP,

Microbe, APhA and more

• Finalizing plans for APhA and ASHP stewardship collaborations

• Developing new partners• CIDRAP and more

Reco

gniti

on • 7 new FIDP inductees

• 4 recognition awards

Publ

icat

ions • Newsletter- stay

tuned Summer/Fall to be released soon

• Coordinated launch of newsletters with Internet/SM team for broader coverage

• Finalizing 2 SIDP Insights publications for submission

Inte

rnet

and

Soc

ial

Med

ia • Website update & directory

• > 5000 twitter followers

• Social media coverage of > 10 international conferences

• Twitter chats with more than 2 million impressions Re

sear

ch A

war

ds • Ongoing support for previous grant awardees

• Successful RFP process for 2 different awards

• Ocean Spray Research Award

• Young Investigator Research Award

2018 SIDP Ocean SprayResearch Award

Erika J. Ernst, PharmDUniversity of Iowa

”Epidemiology of recurrent urinary tract infection in an insured cohort”

2018 Young Investigator Research Award

Andrew Berti, PharmD, PhDWayne State University

“Antimicrobial combinations to prevent recurrent Staphylococcal Infection”

• SIDP Sponsor Prospectus• Raised >$100,000 from sponsors to

help fund the 2018 SIDP Annual Meeting!!!!

• Raised $95,000 in research grants, education and training grants, and website support

• Developed new SIDP Podcast miniseries “The Itch” in partnership with the Internet/Social Media Committee and our sponsor, ALK

Fundraising

Ready to join a committee?The SIDP committee service form is available online.

Type the URL into your browser

https://goo.gl/5Xh1zoYou will be asked to provide some general information

as well as conflict of interest

Annual Meeting San Francisco CA October 2, 2018

Strategic Planning and By-Laws Vote

Annual Meeting San Francisco CA October 2, 2018

Strategic PlanningKerry LaPlante, PharmD, FCCP, FIDSA

President-elect

Strategic Planning • Focus energy and resources• Strengthen operations • Ensures that future boards, chairpersons

and members are working toward common goals

• Establish agreement around intended outcomes/results, and assess and adjust the organization's direction in response to a changing environment.

• Sets priorities

Planning Process

Interviews of Past Presidents,

Committee Chairs, Industry Partners

and Board

Develop & Disseminate Membership

Survey

Develop Vision, Mission, Values

and Goals

Qualitative interviewing

Quantitative survey

Goal: An Inclusive Process

Created our3 year plan

Where have we been?

46

SIDP Purpose Statement• Advance the subspecialty of infectious diseases pharmacotherapy in

clinical pharmacy

• Promote, by way of scientific and professional communication, the contributions and role of pharmacists in the management of infectious diseases

• Develop interdisciplinary relationships between the Society and other professional and regulatory organizations involved in the prevention and management of infectious diseases

SIDP Purpose Statement

• Encourage, develop, and maintain standards of practice for individuals with expertise in the pharmacotherapy and management of infectious diseases

• Support and promote research addressing the epidemiology, treatment, and prevention of infectious diseases; the appropriate use of antimicrobials; and the prevention and management of antimicrobial resistance

Society of Infectious Diseases Pharmacists (SIDP)~ 2018 to 2021 ~

~ Vision ~ Safe and effective antimicrobials for now and the future

~ Mission ~ADVANCE infectious diseases pharmacy and LEADantimicrobial stewardship to OPTIMIZE the care of

patients with infections

• Challenge, empower, and mentor our members to achieve the highest levels of professional excellence.

• Innovate and collaborate to create solutions that advance effective use of antimicrobials.

• Embrace and promote a culture integrity and transparency.

~ SIDP Values ~

COMMUNICATIONS

RESEARCH

MEMBERSHIP

EDUCATION & PRACTICE

ADVOCACY

SOCIETY OPERATIONS

SIDP’s Priority Areas

2018-2021

~ COMMUNICATION ~SIDP Mission Driven Priority #1

GOAL: Advance the mission of the Society through communications that will facilitate internal and external engagement and growth

OUTCOME: Expand internal communications and increase external communications

Primary Responsible Team (PRT):Communications

~ ADVOCACY ~SIDP Mission Driven Priority #2

STRATEGY: Develop a strategic policy platform to advance infectious diseases pharmacy practice, and antimicrobial stewardship in advocacy, education and research.

Outcome: Increase advocacy for the profession of ID pharmacy; coalition building across the pharmacy profession and the field of infectious disease.

Primary Responsible Team (PRT):Advocacy

~ EDUCATION AND PRACTICE ~SIDP Mission Driven Priority #3

STRATEGY: Develop a diverse, effective, high quality portfolio of educational programs that will advance our profession, and contribute to the knowledge of the health care community

Outcome: Expand educational pipeline; inter-professional educational offerings; evaluate AMS training certificates.

Primary Responsible Team (PRT):Education & Practice

~ RESEARCH ~SIDP Mission Driven Priority #4

STRATEGY: Promote and support innovative research in infectious diseases pharmacotherapy, antimicrobial resistance, and antimicrobial stewardship to improve patient outcomes.

Outcome: Develop a research agenda for the Society; facilitate research collaborations and mentorships.

Primary Responsible Team (PRT):Membership & Research

~ MEMBERSHIP ~SIDP Mission Driven Priority #5

STRATEGY: Actively engage members through participation in timely educational, practice and research material to enhance professional development and infectious diseases pharmacy.

Outcome: Develop pharmacists as leaders; increase connectivity across membership.

Primary Responsible Team (PRT):Membership

~ SOCIETY OPERATIONS ~SIDP Mission Driven Priority #6

STRATEGY: Develop and operate a highly effective, efficient and financially self-sufficient organization that is responsive to the Society’s mission

Outcome: Financial sustainability; effective governance; internal cognizance and consistency.

Primary Responsible Teams (PRT):Governance and Finance

58

Vision

Mission

Values

Strategic Plan

Bylaws, Playbook, SOPs

Patients

59

New Committee Structure

Improves Communications& Society Operations

SIDPCommittees

Annual Report

Elections

Fundraising

Internet/Social Media

Inter-Organizational Engagement

Membership

Political AdvocacyProgram

Publications

Recognition

Research

SIDPEC

Stewardship

13 SIDP Committees 2017

History: SIDP committees were first developed in January 1992. Six committees were formed and charged with various functions within the Society: • Program Committee, • Research Committee, • Elections Committee, • Finance Committee, • Publications Committee, • Membership Committee

Throughout the years, additional committees have been added to address emerging and important issues relevant to SIDP and its members while committees no longer needed were dissolved

Committee Structure

61

New Committee Structure:

1. Increase bidirectional communication between Board and Committee leadership

2. decrease duplication of efforts

3. Streamline efforts / decrease silos between committees

Response: Create Basecamp Committee Leadership

Team Provide weekly / biweekly updates from SIDP

President Board member will Chair Standing committee

(One Board Member per Standing Committee) Create thematic working groups to increase

cross pollination

62

63

Committees:Chair, PRP Implements ChargesVice Chair, Understudy of ChairPast Chair, Advisor

TeamsDirector, Board Member

ADVOCACY TeamDirected by: Kerry LaPlante, PharmD

GuidelinesPolitical Patient

.

Inter-organizational & Engagement

Professional Advocacy Public Outreach

64

Kristi Kuper, PharmD, BCPSSenior Clinical Manager,Infectious Diseases, Vizient

Jeffrey J. Cies, PharmD, MPH, BCPS-AQ ID, BCPPS, FCCP, FCCMPharmacy Clinical CoordinatorCritical Care Clinical PharmacistInfectious Diseases Clinical PharmacistSt. Christopher’s Hospital for Children

Susan Davis, PharmDWayne State UniversityHenry Ford Hospital

Chair to be determined..…

FINANCE TeamDirected by Emily Heil, PharmD

Political Audit Fundraising Annual Report

.

65

Montgomery F. Williams, PharmD, BCPS Belmont University College of Pharmacy Department of Pharmacy Practice

Julie Ann Justo, Pharm.D., MS, BCPS-AQ IDAssistant Professor / Clinical Pharmacy and Outcomes SciencesUniversity of South Carolina

David Bearden, Pharm.D.Department Chair ,Oregon State University

COMMUNICATIONS TeamDirected by Jason Pogue, PharmD

Inter-Org PartnershipsPolitical Patient

.

Publications & Podcasts Social Media Website

.

66

Helen Newland, PharmD, BCPSPharmacist, Patient-Centered Outcomes at BJC HealthCare

David Ha, PharmDAssistant Professor of Clinical Sciences at Keck Graduate Institute School of Pharmacy

Margaret Cook, PharmD BCPSSpecialty Pharmacy Coordinator, Infectious Disease

MEMBERSHIP & RESEARCH Team:Directed by Amy Pakyz, PharmD

Inter-Org PartnershipsPolitical Patient

.

Recognitions New Members Research

.

67

Lauren Cochran PharmD, BCPSMedical Science Liaison at Theravance Biopharma

Molly E Steed, PharmDClinical Assistant ProfessorUniversity of Kansas

Betsy Hirsch, PharmD, RPhAssistant ProfessorUniversity of Minnesota College of Pharmacy

Education & Practice TeamDirected by Doug Fish, PharmD

BCIDPPolitical Patient

.

StewardshipSIDPEC Programs

68

Meghan N. Jeffres, PharmDAssistant Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus

Keith Teelucksingh, Pharm.D, BCPS AQ-ID| Division Infectious Disease Pharmacist, South Atlantic DivisionHealthTrust Supply Chain

Melissa Johnson, PharmD, MHS, AAHIVPLiasion Clinical PharmacistAssociate Professor of Medicine, Duke University

Chair to be determined…

GOVERNANCE TEAM: Directed by Libby Dodds-Ashley, PharmD

Political Strategic Planning Nominations & Bylaws

.

69

Brandon DionnePHARMD, BCPS, AAHIVPAssistant Clinical Professor in the Department of Pharmacy and Health Systems

Elizabeth D. Hermsen, Pharm.D., M.B.A., is the head of Global Antimicrobial Stewardship at Merck & Co., Inc

Ready to join a committee?The SIDP committee service form is available online.

Type the URL into your browser

https://goo.gl/5Xh1zoYou will be asked to provide some general information

as well as conflict of interest

Annual Meeting San Francisco CA October 2, 2018

Strategic Planning and By-Laws Vote

Libby Dodds-Ashley, PharmD

Changes to By-Laws• Revisions drafted and reviewed by board, past-presidents

and attorney• Membership notified on 8/31/2018 Period for on-line and email comment All available comments discussed at board retreat

• It is now time to vote Paper ballots were distributed to voting members at registration

Summary of Changes• Updated with new mission and vision• Provision for more flexible voting and by-laws revisions No more paper ballots

• Changes to membership requirements No letter requirement for Associate Members

• Dues set by board after period of member comment

• Please return ballots to registration desk

• Voting closes at the start of the reception

Annual Meeting San Francisco CA October 2, 2018

Advocacy in SIDP

Political Advocacy and Expanding Visibility of SIDP

Enhancing reach of advocacy efforts

Collaboration with partner organizations

Promotion of advocacy to membership and nationally

Advocacy for ID Pharmacist at National and State Level (Policy) HHS National Action Plan to Prevent Health Care Associated Infections Road Map to Elimination US Market Entry Reward (MERS) Pandemic and All-Hazards Preparedness Act (PHAPA) reauthorization Pharmacist representative Presidents Advisory Counsel Combating Antibiotics Resistant Bacteria

(PACCARB) Re-Valuing Anti-Microbial Products Act of 2018 (REVAMP) Oppose Proposed Regulations Implementing Keeping Antibiotics Effective Act that Fail to Comply

with Legislative Intent (COMAR) Letter to Codex re: support for WHO guidelines National Institutes of Food and Agriculture (NIFA) funded research on antibiotic resistance Strategies to Address Antibiotic Resistance Act (STAAR Act)

And many others . . . .

Advocacy for ID Pharmacist at National and State Level (Partnerships)

SIDP Supports the #GlobalAMRChallenge

More details: https://www.cdc.gov/drugresistance/intl-activities/amr-challenge.html

Coming Soon!!

Annual Meeting San Francisco CA October 2, 2018

Recognition Awards

The purpose of this award is recognize a significant contribution to the peer-reviewed literature in infectious diseases pharmacotherapy by an active or associate SIDP member

Nominees are evaluated primarily based on their contribution to the paper and the impact or significance of the publication.

Infectious Diseases Pharmacotherapy Paper Award

2018 Infectious Diseases Pharmacotherapy Paper Award

Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Matusiak LM, Schumock GT.

Antibiotic expenditures by medication, class, and healthcare setting in the United States, 2010-2015Clin Infect Dis. 2018 Jan 6;66(2):185-190

Katie J. Suda

Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy

Award

The purpose of this award is recognize an SIDP member who has developed an innovative and/or excellent clinical practice site

Areas of contribution to infectious diseases pharmacotherapy may include, but are not limited to, development of innovative services, documentation of benefits, and methods of promoting the safe, effective, and rational use of anti-infective agents.

2018 Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy

Award

Ashley M. WildeNorton HealthcareLouisville, Kentucky

Young Investigator AwardThe purpose of this award is to:• Recognize past research accomplishments• Reward young investigators who show research

promise in the broad area of infectious diseases

Preference is given to independent research work conducted after completion of terminal education and training. Nominees are evaluated on research funding, publication record, leadership, teaching and honors or awards received for their research.

2018 Young Investigator Award

Brian J. WerthUniversity of Washington School of Pharmacy

Gita Patel AwardThis purpose of this award is to:• Recognize an SIDP member who has implemented and

documented the impact of an innovative or collaborative “best practice” initiative to improve care in patients with infectious diseases

Preference is given to pharmacists providing patient care in the community setting and to those that do not receive salary support dedicated to research. Previous formal infectious disease training is not a requirement.

2018 Gita Patel Award

Elias B. ChahinePalm Beach Atlantic UniversityWellington Regional Medical Center

Fellows of the Society of Infectious Diseases Pharmacist

Libby Dodds Ashley, PharmD, MHS, FCCP, BCPSSIDP President

Fellowship in SIDP (FIDP)• This distinction recognizes outstanding SIDP members with significant and sustained

contributions to infectious diseases and the mission of SIDP

• Successful applicants demonstrate excellence in the following areas: Contributions to SIDP (*Required Category)

AND at least 2 of the following categories: Practice Education Scholarship

• Detailed application and supporting documentation evaluated using an objective scoring rubric Specific minimum scores set for each category

Annual Meeting San Francisco CA October 2, 2018

Fellows of SIDP2018

Fellow of SIDP 2018

Steven L. Barriere, PharmD, FIDSA, FCCP, FIDP

Annual Meeting San Francisco CA October 2, 2018

Fellows of SIDP2018

Fellow of SIDP 2018

David T. Bearden, PharmD, FIDP

Annual Meeting San Francisco CA October 2, 2018

Fellows of SIDP2018

Fellow of SIDP 2018

John A. Bosso, PharmD, FIDSA, FCCP, FIDP

Annual Meeting San Francisco CA October 2, 2018

Fellows of SIDP2018

Fellow of SIDP 2018

Douglas N. Fish, PharmD, FCCM, FCCP, BCCCP, BCPS (AQ-ID), FIDP

Annual Meeting San Francisco CA October 2, 2018

Fellows of SIDP2018

Fellow of SIDP 2018

Jason C. Gallagher, PharmD, FCCP, FIDSA, BCPS, FIDP

Annual Meeting San Francisco CA October 2, 2018

Fellows of SIDP2018

Fellow of SIDP 2018

Paul O. Gubbins, PharmD, FCCP, FIDP

Annual Meeting San Francisco CA October 2, 2018

Fellows of SIDP2018

Fellow of SIDP 2018

John F. Mohr III, PharmD, FIDP

Outgoing Leaders

Incoming President 2018-2019

Kerry LaPlante, PharmD, FCCPProfessor of Pharmacy, University of Rhode Island Adjunct Professor of Medicine, Brown UniversityID Specialist, Providence Veterans Affairs Medical Center

SIDPs 27th President 2017-2018

Libby Dodds Ashley, PharmD, MHS, FCCP, BCPSAssociate Professor, DASON Clinical PharmacistDuke Antibiotic Stewardship Outreach Network (DASON), Duke University Medical Center

Annual Meeting San Francisco CA October 2, 2018

Incoming President Remarks

2018

LeadershipThe true measure of leadership is influence nothing more, nothing less…..

DEADLINE to submit – November 2, 2018The CE sessions are partially supported by an

educational grant from BioFire Diagnostics.

Reminders!• Thank you SIDP members for all you do• Please turn in your ballots for the by-laws

vote• Thank you to our meeting sponsors• Enjoy the reception – Sponsored by

CutisPharma